[Other] Peri-transplant ruxolitinib in myelofibrosis patients undergoing αβTCR and CD19-depleted stem cell transplantation

Kalyan@123 Post time Half hour(s) ago | Show all posts |Read mode

This post will be closed automatically in 2026-10-25 12:49

Reward10points

journal：Bone Marrow Transplantation

Authors：Stuut, A., Weverling, F., Janssen, A. et al. Peri-transplant ruxolitinib in myelofibrosis patients undergoing αβTCR and CD19-depleted stem cell transplantation. Bone Marrow Transplant (2026). https://doi.org/10.1038/s41409-026-03063-0

Published date：2026

DOI：10.1038/s41409-026-03063-0

PDF link：https://www.pidantuan.com/forum.php?mod=post&action=newthread&fid=66&special=3

Article link：https://www.pidantuan.com/forum.php?mod=post&action=newthread&fid=66&special=3

Article Source：springer。

Remark：Please provide the article pdf on urgent basis